First Time Loading...

3SBio Inc
HKEX:1530

Watchlist Manager
3SBio Inc Logo
3SBio Inc
HKEX:1530
Watchlist
Price: 6.22 HKD -1.43% Market Closed
Updated: May 24, 2024

3SBio Inc
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

3SBio Inc
Cost of Revenue Peer Comparison

Comparables:
6160
1801
603392
300122
300896

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
3SBio Inc
HKEX:1530
Cost of Revenue
-¥1.2B
CAGR 3-Years
-3%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Cost of Revenue
-¥2.7B
CAGR 3-Years
-77%
CAGR 5-Years
-70%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Cost of Revenue
-¥1.1B
CAGR 3-Years
-43%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Cost of Revenue
-¥992.7m
CAGR 3-Years
-28%
CAGR 5-Years
-29%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Cost of Revenue
-¥39.6B
CAGR 3-Years
-58%
CAGR 5-Years
-63%
CAGR 10-Years
-63%
Imeik Technology Development Co Ltd
SZSE:300896
Cost of Revenue
-¥99.9m
CAGR 3-Years
-34%
CAGR 5-Years
-27%
CAGR 10-Years
N/A

See Also

What is 3SBio Inc's Cost of Revenue?
Cost of Revenue
-1.2B CNY

Based on the financial report for Dec 31, 2023, 3SBio Inc's Cost of Revenue amounts to -1.2B CNY.

What is 3SBio Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-6%

Over the last year, the Cost of Revenue growth was 2%. The average annual Cost of Revenue growth rates for 3SBio Inc have been -3% over the past three years , -6% over the past five years .